is wegovy a tirzepatide better than mounjaro Mounjaro vs The FDA approval of #zepbound

Retrieved from Bakshi, A

On the medication side, GLP-1 receptor agonists like semaglutide and tirzepatide have a robust evidence base in their FDA-approved finished forms

Managing gastrointestinal side-effects and preventing treatment discontinuation with GLP-1 therapies GI symptoms are the most common adverse effects of GLP-1 therapies, with nausea, constipation, diarrhea, and vomiting occurring in around 40 % of patients [11,[30], [31], [32]]

Diabetic retinopathy: management and monitoring (NG242) evidence review C

As for why people opted to microdose, avoiding side effects was the main reason for 66 percent of microdosers, while 38 percent said they did it to save money